Compound heterozygous mutations in the SSPOP gene lead to epilepsy and developmental disorders
Brain · 2025
DOI: 10.1093/brain/awaf327 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain, 2025. Verfasst von Aojie Cai und 7 weiteren Autor:innen. Beteiligte Einrichtung: Children's Medical Center, Peking University First Hospital, Beijing 102627, China. Hauptthemen laut MEDLINE: Epilepsy, Mutation, Developmental Disabilities, Neurodevelopmental Disorders. Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China, Key Project of Clinical Medicine Research.
Abstract (Originalsprache)
The SSPOP gene, currently classified as a pseudogene in the human genome, encodes the SCO-spondin protein, which plays an important role in human neurodevelopment, though its function remains poorly understood. In this study, we used trio-based whole exome sequencing to identify compound heterozygous SSPOP variants in four children from three unrelated families, including one pair of dizygotic twins. These children exhibited variable phenotypes, including variation in age of onset, seizure semiology, and response to antiseizure medications, along with neurodevelopmental disorders. We demonstrated that SSPOP is a functional gene by confirming its expression at both the transcriptional and protein levels. We analysed ten brain tissue samples from seven pediatric patients and brain organoids derived from human iPSCs to confirm its expression via qRT-PCR, immunofluorescence and Western blotting, supporting its biological function during both prenatal and postnatal stages of brain development. In addition, CRISPR-mediated sspo knockout zebrafish demonstrated abnormal neurodevelopment and epileptic discharges in vivo. Together, these findings suggest that SSPOP is a functional gene and a potential contributor to neurodevelopmental disorders and epilepsy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Children's Medical Center, Peking University First Hospital, Beijing 102627, China.
- Department of Pediatrics, Children's Hospital of the First Affiliated Hospital of Zhengzhou University, Henan 450000, China.
- Beijing Key Laboratory of Molecular Diagnosis and Study on Pediatric Genetic Diseases, Beijing 102627, China.
- Children Epilepsy Center, Peking University First Hospital, Beijing 102627, China.
- Key Laboratory for Neuroscience, Ministry of Education/National Health and Family Planning Commission, Peking University, Beijing 102627, China.
- Center of Epilepsy, Beijing Institute for Brain Disorders, Beijing 102627, China.
Förderung
- National Natural Science Foundation of China
- National Key Research and Development Program of China
- Key Project of Clinical Medicine Research
- National Clinical Research Center for Child Health and Disorders
- Children's Hospital of Chongqing Medical University
- Beijing Natural Science Foundation
- Beijing Key Laboratory of Molecular Diagnosis
- Pediatric Genetic Diseases
Zitieren
APA
Cai, A., Zhang, F., Li, J., Wang, J., Wu, Y., Zhang, Y., Gao, K., & Jiang, Y. (2025). Compound heterozygous mutations in the SSPOP gene lead to epilepsy and developmental disorders. Brain. https://doi.org/10.1093/brain/awaf327
Vancouver
Cai A, Zhang F, Li J, Wang J, Wu Y, Zhang Y, et al. Compound heterozygous mutations in the SSPOP gene lead to epilepsy and developmental disorders. Brain. 2025. doi:10.1093/brain/awaf327
BibTeX
@article{Cai2025,
author = {Cai, Aojie and Zhang, Fan and Li, Jinliang and Wang, Jingmin and Wu, Ye and Zhang, Yuehua and Gao, Kai and Jiang, Yuwu},
title = {Compound heterozygous mutations in the SSPOP gene lead to epilepsy and developmental disorders},
journal = {Brain},
year = {2025},
doi = {10.1093/brain/awaf327}
}
EUVIMED